Europe Cancer Supportive Care Medicine Market Report 2018
SKU ID :XYZResearch -11834340 | Published Date: 30-Nov--0001 | No. of pages: 116Description
TOC
Table of Contents
Europe Cancer Supportive Care Medicine Market Report 2012-2023
1 Cancer Supportive Care Medicine Overview
1.1 Product Overview and Scope of Cancer Supportive Care Medicine
1.2 Classification of Cancer Supportive Care Medicine by Product Category
1.2.1 Europe Cancer Supportive Care Medicine Sales (K Units) Comparison by Types (2012-2023)
1.2.2 Europe Cancer Supportive Care Medicine Sales (K Units) Market Share by Types in 2017
1.2.3 Antiemetic Drugs
1.2.4 Erythropoietin-Stimulating Agents
1.2.5 Granulocyte-Stimulating Agents
1.2.6 Analgesics
1.2.7 Others
1.3 Europe Cancer Supportive Care Medicine Market by Application/End Users
1.3.1 Europe Cancer Supportive Care Medicine (K Units) and Market Share Comparison by Applications (2012-2023)
1.3.2 Chemotherapy-Induced Anemia
1.3.3 CINV
1.3.4 Bone Metastasis
1.3.5 Cancer Pain
1.3.6 Other
1.4 Europe Cancer Supportive Care Medicine Market by Region
1.4.1 Europe Cancer Supportive Care Medicine Revenue (Million USD) Comparison by Regions (2012-2023)
1.4.2 Germany Status and Prospect (2012-2023)
1.4.3 UK Status and Prospect (2012-2023)
1.4.4 France Status and Prospect (2012-2023)
1.4.5 Russia Status and Prospect (2012-2023)
1.4.6 Benelux Status and Prospect (2012-2023)
1.4.7 Italy Status and Prospect (2012-2023)
1.4.8 Spain Status and Prospect (2012-2023)
1.5 Europe Sales and Revenue ofSales and Revenue of Cancer Supportive Care Medicine (2012-2023)
1.5.1 Europe Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2023)
1.5.2 Europe Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023)
2 Industrial Chain Analysis
2.1 Industry Chain Structure of Cancer Supportive Care Medicine
2.2 Raw Material Analysis of Cancer Supportive Care Medicine
2.1.1 Raw Material A Market Analysis
2.1.2 Raw Material B Market Analysis
2.1.3 Raw Material C Market Analysis
2.3 Labor Cost Analysis of Cancer Supportive Care Medicine
2.4 Other Costs Analysis of Cancer Supportive Care Medicine
2.5 Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine
2.6 Manufacturing Process Analysis of Cancer Supportive Care Medicine
2.7 Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers in 2018
2.8 Downstream Buyers
3 Europe Cancer Supportive Care Medicine Players/Suppliers Profiles and Sales Data
3.1 Amgen
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Cancer Supportive Care Medicine Product Category, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 Amgen Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.1.4 Amgen Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.1.5 Amgen Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share
3.2 Helsinn Healthcare
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Cancer Supportive Care Medicine Product Category, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Helsinn Healthcare Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.2.4 Helsinn Healthcare Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.2.5 Helsinn Healthcare Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share
3.3 Johnson &Johnson
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Cancer Supportive Care Medicine Product Category, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Johnson &Johnson Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.3.4 Johnson &Johnson Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.3.5 Johnson &Johnson Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share
3.4 Merck
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Cancer Supportive Care Medicine Product Category, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 Merck Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.4.4 Merck Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.4.5 Merck Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share
3.5 F. Hoffmann-La Roche
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Cancer Supportive Care Medicine Product Category, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.5.4 F. Hoffmann-La Roche Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.5.5 F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share
3.6 GlaxoSmithKline
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Cancer Supportive Care Medicine Product Category, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 GlaxoSmithKline Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.6.4 GlaxoSmithKline Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.6.5 GlaxoSmithKline Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share
3.7 Heron Therapeutics
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Cancer Supportive Care Medicine Product Category, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 Heron Therapeutics Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.7.4 Heron Therapeutics Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.7.5 Heron Therapeutics Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share
3.8 Kyowa Hakko Kirin
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Cancer Supportive Care Medicine Product Category, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.8.4 Kyowa Hakko Kirin Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.8.5 Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share
3.9 Novartis
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Cancer Supportive Care Medicine Product Category, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Novartis Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.9.4 Novartis Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.9.5 Novartis Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share
3.10 TESARO
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Cancer Supportive Care Medicine Product Category, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 TESARO Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.10.4 TESARO Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.10.5 TESARO Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share
3.11 Teva Pharmaceutical Industries
4 Europe Cancer Supportive Care Medicine Competition by Players/Manufacturers, Region, Type and Application
4.1 Europe Cancer Supportive Care Medicine Market Competition by Players/Manufacturers
4.1.1 Europe Cancer Supportive Care Medicine Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017)
4.1.2 Europe Cancer Supportive Care Medicine Revenue (Million USD) and Share by Players/Suppliers (2012-2017)
4.2 Europe Cancer Supportive Care Medicine Sales and Revenue by Type
4.2.1 Europe Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type (2012-2017)
4.2.2 Europe Cancer Supportive Care Medicine Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 Europe Cancer Supportive Care Medicine Sales and Revenue by Application
4.3.1 Europe Cancer Supportive Care Medicine Sales (K Units) and Market Share by Regions (2012-2017)
4.3.2 Europe Cancer Supportive Care Medicine Revenue (Million USD) and Market Share (%) Regions (2012-2017)
4.4 Europe Cancer Supportive Care Medicine Sales (K Units) by Application
5 Germany Cancer Supportive Care Medicine (Sales, Revenue and Price)
5.1 Germany Cancer Supportive Care Medicine Sales and Value (2012-2017)
5.1.1 Germany Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017)
5.1.2 Germany Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017)
5.1.3 Germany Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
5.2 Germany Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type
5.3 Germany Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application
6 UK Cancer Supportive Care Medicine (Sales, Revenue and Price)
6.1 UK Cancer Supportive Care Medicine Sales and Value (2012-2017)
6.1.1 UK Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017)
6.1.2 UK Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017)
6.1.3 UK Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
6.2 UK Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type
6.3 UK Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application
7 France Cancer Supportive Care Medicine (Sales, Revenue and Price)
7.1 France Cancer Supportive Care Medicine Sales and Value (2012-2017)
7.1.1 France Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017)
7.1.2 France Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017)
7.1.3 France Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
7.2 France Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type
7.3 France Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application
8 Russia Cancer Supportive Care Medicine (Sales, Revenue and Price)
8.1 Russia Cancer Supportive Care Medicine Sales and Value (2012-2017)
8.1.1 Russia Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017)
8.1.2 Russia Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017)
8.1.3 Russia Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
8.2 Russia Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type
8.3 Russia Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application
9 Benelux Cancer Supportive Care Medicine (Sales, Revenue and Price)
9.1 Benelux Cancer Supportive Care Medicine Sales and Value (2012-2017)
9.1.1 Benelux Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017)
9.1.2 Benelux Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017)
9.1.3 Benelux Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
9.2 Benelux Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type
9.3 Benelux Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application
10 Italy Cancer Supportive Care Medicine (Sales, Revenue and Price)
10.1 Italy Cancer Supportive Care Medicine Sales and Value (2012-2017)
10.1.1 Italy Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017)
10.1.2 Italy Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017)
10.1.3 Italy Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
10.2 Italy Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type
10.3 Italy Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application
11 Spain Cancer Supportive Care Medicine (Sales, Revenue and Price)
11.1 Spain Cancer Supportive Care Medicine Sales and Value (2012-2017)
11.1.1 Spain Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017)
11.1.2 Spain Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017)
11.1.3 Spain Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
11.2 Spain Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type
11.3 Spain Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Direct Marketing
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Europe Cancer Supportive Care Medicine Market Forecast (2018-2023)
13.1 Europe Cancer Supportive Care Medicine Sales (K Units), Revenue and Price Forecast (2018-2023)
13.1.1 Europe Cancer Supportive Care Medicine Sales (K Units) and Growth Rate Forecast (2018-2023)
13.1.2 Europe Cancer Supportive Care Medicine Revenue and Growth Rate Forecast (2018-2023)
13.1.3 Europe Cancer Supportive Care Medicine Price and Trend Forecast (2018-2023)
13.2 Europe Cancer Supportive Care Medicine Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023)
13.2.1 Europe Cancer Supportive Care Medicine Sales (K Units) and Growth Rate Forecast by Region (2018-2023)
13.2.2 Europe Cancer Supportive Care Medicine Revenue and Growth Rate Forecast by Region (2018-2023)
13.2.3 Germany Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.4 UK Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.5 France Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.6 Russia Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.7 France Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.8 Italy Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023)
13.2.9 Spain Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023)
13.3 Europe Cancer Supportive Care Medicine Sales, Revenue and Price Forecast by Type (2018-2023)
13.3.1 Europe Cancer Supportive Care Medicine Sales Forecast by Type (2018-2023)
13.3.2 Europe Cancer Supportive Care Medicine Revenue Forecast by Type (2018-2023)
13.3.3 Europe Cancer Supportive Care Medicine Price Forecast by Type (2018-2023)
13.4 Europe Cancer Supportive Care Medicine Sales Forecast by Application (2018-2023)
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Disclaimer
Tables & Figures
List of Tables and Figures
Figure Europe Market Size (Million USD) Comparison 2012-2023
Table Europe Market Cancer Supportive Care Medicine Revenue (Million USD) Comparison by Regions 2012-2023
Table Europe Cancer Supportive Care Medicine Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Europe Cancer Supportive Care Medicine Sales (K Units) by Application (2016-2023)
Figure Product Picture of Cancer Supportive Care Medicine
Table Europe Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023)
Figure Europe Cancer Supportive Care Medicine Sales (K Units) Market Share by Types in 2017
Figure Antiemetic Drugs Picture
Figure Erythropoietin-Stimulating Agents Picture
Figure Granulocyte-Stimulating Agents Picture
Table Europe Cancer Supportive Care Medicine Sales (K Units) Comparison by Applications (2012-2023)
Figure Europe Sales Market Share of Cancer Supportive Care Medicine by Applications in 2017
Figure Chemotherapy-Induced Anemia Picture
Figure CINV Picture
Figure Bone Metastasis Picture
Table Europe Market Cancer Supportive Care Medicine Revenue (Million USD) Comparison by Regions 2012-2023
Figure Germany Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023)
Figure UK Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023)
Figure France Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023)
Figure Russia Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023)
Figure Benelux Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023)
Figure Italy Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023)
Figure Spain Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023)
Figure Europe Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2023)
Figure Europe Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023)
Figure New Project SWOT Analysis of Cancer Supportive Care Medicine
Table Industry News List of Cancer Supportive Care Medicine
Figure Industry Chain Structure of Cancer Supportive Care Medicine
Table Raw Material Suppliers and Price Analysis
Figure Global Raw Material A Price Trend (USD/MT)
Figure Global Raw Material B Price Trend (USD/MT)
Figure Global Raw Material C Price Trend (USD/MT)
Table Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine in 2017
Figure Manufacturing Process Analysis of Cancer Supportive Care Medicine
Table Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers Europe
Table Major Buyers of Cancer Supportive Care Medicine
Table Amgen Basic Information List
Table Amgen Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Amgen Cancer Supportive Care Medicine Sales Growth Rate (2012-2017)
Figure Amgen Cancer Supportive Care Medicine Sales Europe Market Share (%) (2012-2017)
Figure Amgen Cancer Supportive Care Medicine Revenue Europe Market Share (%) (2012-2017)
Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Amgen Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share
Table Amgen Cancer Supportive Care Medicine Volume in CINV and Its Application Share
Table Amgen Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share
Table Helsinn Healthcare Basic Information List
Table Helsinn Healthcare Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Helsinn Healthcare Cancer Supportive Care Medicine Sales Growth Rate (2012-2017)
Figure Helsinn Healthcare Cancer Supportive Care Medicine Sales Europe Market Share (%) (2012-2017)
Figure Helsinn Healthcare Cancer Supportive Care Medicine Revenue Europe Market Share (%) (2012-2017)
Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share
Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in CINV and Its Application Share
Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share
Table Johnson &Johnson Basic Information List
Table Johnson &Johnson Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Johnson &Johnson Cancer Supportive Care Medicine Sales Growth Rate (2012-2017)
Figure Johnson &Johnson Cancer Supportive Care Medicine Sales Europe Market Share (%) (2012-2017)
Figure Johnson &Johnson Cancer Supportive Care Medicine Revenue Europe Market Share (%) (2012-2017)
Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Johnson &Johnson Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share
Table Johnson &Johnson Cancer Supportive Care Medicine Volume in CINV and Its Application Share
Table Johnson &Johnson Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share
Table Merck Basic Information List
Table Merck Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Merck Cancer Supportive Care Medicine Sales Growth Rate (2012-2017)
Figure Merck Cancer Supportive Care Medicine Sales Europe Market Share (%) (2012-2017)
Figure Merck Cancer Supportive Care Medicine Revenue Europe Market Share (%) (2012-2017)
Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Merck Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share
Table Merck Cancer Supportive Care Medicine Volume in CINV and Its Application Share
Table Merck Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales Europe Market Share (%) (2012-2017)
Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Revenue Europe Market Share (%) (2012-2017)
Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share
Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in CINV and Its Application Share
Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure GlaxoSmithKline Cancer Supportive Care Medicine Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Cancer Supportive Care Medicine Sales Europe Market Share (%) (2012-2017)
Figure GlaxoSmithKline Cancer Supportive Care Medicine Revenue Europe Market Share (%) (2012-2017)
Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share
Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in CINV and Its Application Share
Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share
Table Heron Therapeutics Basic Information List
Table Heron Therapeutics Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Heron Therapeutics Cancer Supportive Care Medicine Sales Growth Rate (2012-2017)
Figure Heron Therapeutics Cancer Supportive Care Medicine Sales Europe Market Share (%) (2012-2017)
Figure Heron Therapeutics Cancer Supportive Care Medicine Revenue Europe Market Share (%) (2012-2017)
Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Heron Therapeutics Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share
Table Heron Therapeutics Cancer Supportive Care Medicine Volume in CINV and Its Application Share
Table Heron Therapeutics Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales Growth Rate (2012-2017)
Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales Europe Market Share (%) (2012-2017)
Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Revenue Europe Market Share (%) (2012-2017)
Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in CINV and Its Application Share
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share
Table Novartis Basic Information List
Table Novartis Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Novartis Cancer Supportive Care Medicine Sales Growth Rate (2012-2017)
Figure Novartis Cancer Supportive Care Medicine Sales Europe Market Share (%) (2012-2017)
Figure Novartis Cancer Supportive Care Medicine Revenue Europe Market Share (%) (2012-2017)
Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Novartis Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share
Table Novartis Cancer Supportive Care Medicine Volume in CINV and Its Application Share
Table Novartis Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share
Table Company TESARO Basic Information List
Table Company TESARO Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Company TESARO Cancer Supportive Care Medicine Sales Growth Rate (2012-2017)
Figure Company TESARO Cancer Supportive Care Medicine Sales Europe Market Share (%) (2012-2017)
Figure Company TESARO Cancer Supportive Care Medicine Revenue Europe Market Share (%) (2012-2017)
Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
Table Company TESARO Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share
Table Company TESARO Cancer Supportive Care Medicine Volume in CINV and Its Application Share
Table Company TESARO Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share
Table Europe Cancer Supportive Care Medicine Sales (K Units) by Players/Manufacturers (2012-2017)
Table Europe Cancer Supportive Care Medicine Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 Europe Cancer Supportive Care Medicine Sales Market Share (%) by Players/Manufacturers
Figure 2017 Europe Cancer Supportive Care Medicine Sales Share by Players/Manufacturers
Table Europe Cancer Supportive Care Medicine Revenue (Million USD) by Players/Manufacturers (2012-2017)
Table Europe Cancer Supportive Care Medicine Revenue Market Share (%) Players/Manufacturers (2012-2017)
Figure 2016 Europe Cancer Supportive Care Medicine Revenue Market Share (%) Players
Figure 2017 Europe Cancer Supportive Care Medicine Revenue Market Share (%) Players
Table Europe Cancer Supportive Care Medicine Sales (K Units) and Market Share (%) by Type (2012-2017)
Table Europe Cancer Supportive Care Medicine Sales Share by Type (2012-2017)
Figure Sales Market Share of Cancer Supportive Care Medicine by Type (2012-2017)
Figure Europe Cancer Supportive Care Medicine Sales Growth Rate (%) by Type (2012-2017)
Table Europe Cancer Supportive Care Medicine Revenue (Million USD) and Market Share (%) Type (2012-2017)
Table Europe Cancer Supportive Care Medicine Revenue Market Share (%) Type (2012-2017)
Figure Revenue Market Share of Cancer Supportive Care Medicine by Type (2012-2017)
Figure Europe Cancer Supportive Care Medicine Revenue Growth Rate by Type (2012-2017)
Table Europe Cancer Supportive Care Medicine Sales (K Units) and Market Share by Regions (2012-2017)
Table Europe Cancer Supportive Care Medicine Sales Share by Regions (2012-2017)
Figure Sales Market Share of Cancer Supportive Care Medicine by Regions (2012-2017)
Figure Europe Cancer Supportive Care Medicine Sales Market Share by Regions in 2017
Table Europe Cancer Supportive Care Medicine Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Europe Cancer Supportive Care Medicine Revenue Share (%) by Regions (2012-2017)
Figure Revenue Market Share of Cancer Supportive Care Medicine by Regions (2012-2017)
Figure Europe Cancer Supportive Care Medicine Revenue Market Share by Regions in 2017
Table Europe Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application (2012-2017)
Table Europe Cancer Supportive Care Medicine Sales Share (%) by Application (2012-2017)
Figure Europe Cancer Supportive Care Medicine Sales Market Share by Application (2012-2017)
Figure Europe Cancer Supportive Care Medicine Sales Market Share by Application (2012-2017)
Figure Germany Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) (2012-2017)
Figure Germany Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Germany Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Germany Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017)
Table Germany Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017)
Figure Germany Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017
Table Germany Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017)
Table Germany Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017)
Figure Germany Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017
Figure UK Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure UK Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure UK Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table UK Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017)
Table UK Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017)
Figure UK Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017
Table UK Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017)
Table UK Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017)
Figure UK Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017
Figure France Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure France Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure France Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table France Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017)
Table France Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017)
Figure France Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017
Table France Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017)
Table France Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017)
Figure France Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017
Figure Russia Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Russia Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Russia Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017)
Table Russia Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017)
Figure Russia Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017
Table Russia Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017)
Table Russia Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017)
Figure Russia Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017
Figure Italy Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Italy Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Italy Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017)
Table Italy Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017)
Figure Italy Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017
Table Italy Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017)
Table Italy Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017)
Figure Italy Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017
Figure Benelux Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Benelux Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Benelux Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017)
Table Benelux Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017)
Figure Benelux Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017
Table Benelux Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017)
Table Benelux Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017)
Figure Benelux Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017
Figure Spain Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Spain Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017)
Figure Spain Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017)
Table Spain Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017)
Table Spain Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017)
Figure Spain Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017
Table Spain Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017)
Table Spain Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017)
Figure Spain Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017
Table Distributors/Traders List
Figure Europe Cancer Supportive Care Medicine Sales (K Units) and Growth Rate Forecast (2018-2023)
Figure Europe Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Europe Cancer Supportive Care Medicine Price and Trend Forecast (2018-2023)
Table Europe Cancer Supportive Care Medicine Sales (K Units) Forecast by Regions (2018-2023)
Figure Europe Cancer Supportive Care Medicine Sales (K Units) Market Share Forecast by Regions (2018-2023)
Figure Europe Cancer Supportive Care Medicine Sales (K Units) Market Share Forecast by Regions in 2023
Table Europe Cancer Supportive Care Medicine Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Europe Cancer Supportive Care Medicine Revenue Market Share Forecast by Regions (2018-2023)
Figure Europe Cancer Supportive Care Medicine Revenue Market Share Forecast by Regions in 2023
Figure Germany Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Germany Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure France Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure France Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure UK Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure UK Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Russia Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Russia Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Benelux Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Benelux Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Italy Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Italy Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Figure Spain Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023)
Figure Spain Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023)
Table Europe Cancer Supportive Care Medicine Sales (K Units) Forecast by Type (2018-2023)
Figure Europe Cancer Supportive Care Medicine Sales Market Share Forecast by Type (2018-2023)
Table Europe Cancer Supportive Care Medicine Revenue (Million USD) Forecast by Type (2018-2023)
Figure Europe Cancer Supportive Care Medicine Revenue Market Share Forecast by Type (2018-2023)
Table Europe Cancer Supportive Care Medicine Price (USD/Unit) Forecast by Type (2018-2023)
Table Europe Cancer Supportive Care Medicine Sales (K Units) Forecast by Application (2018-2023)
Figure Europe Cancer Supportive Care Medicine Sales Market Share Forecast by Application (2018-2023)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Companies
Amgen
Helsinn Healthcare
Johnson &Johnson
Merck
F. Hoffmann-La Roche
GlaxoSmithKline
Heron Therapeutics
Kyowa Hakko Kirin
Novartis
TESARO
Teva Pharmaceutical Industries
- PRICE
-
$3450$6800